Materna Medical

Executive Summary

Materna Medical is a privately held medical device company dedicated to improving women's pelvic health, addressing conditions such as vaginismus (pelvic floor muscle tightness) and birth-related pelvic floor injuries. Founded in 2015 and headquartered in San Carlos, California, the company develops innovative solutions to protect and restore pelvic health across a woman's lifespan. The company's technology targets a significant unmet need, as pelvic floor disorders affect millions of women globally, yet remain underdiagnosed and undertreated. Materna Medical's approach leverages proprietary devices designed for non-invasive or minimally invasive treatment, aiming to provide effective alternatives to existing therapies like physical therapy or surgery. The company is currently in the Phase 1 stage, indicating early clinical development. While specific financial or clinical details are limited, the company's focus on a high-demand women's health niche positions it for potential growth if its technology proves safe and effective. With a small but dedicated team, Materna Medical is likely seeking additional funding or partnerships to advance its pipeline. Success in early trials could pave the way for regulatory submissions, such as FDA 510(k) clearance, and eventual commercialization. The company remains at a high-risk, high-reward stage typical of early-stage medical device firms.

Upcoming Catalysts (preview)

• Q4 2026Completion of Phase 1 clinical trial for pelvic floor device70% success
• Q2 2027FDA 510(k) submission for vaginismus treatment device60% success
• Q1 2027Series A or B funding round announcement75% success